Trump Announcement Today Targets High Drug Costs in the USAdvtTrumpRx Program Could Lower Cash-Pay Drug Costs NationwideMerck to Offer Discounts on Diabetes Drugs Under TrumpRxMajor Drugmakers Sign On to Trump Rx Pricing PlanAdvtMost-Favored-Nation Pricing Central to Trump Drug Prices StrategyWhat Comes Next After Trump’s Drug Price AnnouncementFAQsBy ,ET BureauJoin the community of 2M+ industry professionals. Download the ETPharma App and get the Realtime updates and Save your favourite articles. Drugmakers also agreed that new drugs introduced in the US will be priced no higher than those in other wealthy countries. If approved, Merck’s experimental cholesterol drug enlicitide will also be offered through direct-to-consumer channels. Five companies, Pfizer, Eli Lilly, AstraZeneca, Novo Nordisk, and EMD Serono, had already reached similar deals with the administration.Three major companies, Regeneron, Johnson & Johnson, and AbbVie, have yet to announce agreements.

Source: Economic Times December 20, 2025 09:19 UTC